HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Orpiszewski, J. Articles by Aswad, D. W. Search for Related Content PubMed PubMed Citation Articles by Orpiszewski, J. Articles by Aswad, D. W. Social Bookmarking                      What's this?

Volume 271, Number 38, Issue of September 20, 1996 pp. 22965-22968
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

COMMUNICATION:
High Mass Methyl-accepting Protein (HMAP), a Highly Effective Endogenous Substrate for Protein -Isoaspartyl Methyltransferase in Mammalian Brain

(Received for publication, June 20, 1996, and in revised form, July 25, 1996)

From the Department of Molecular Biology & Biochemistry, University of California, Irvine, California 92697-3900

A previously unidentified endogenous substrate for protein -isoaspartyl methyltransferase in mammalian brain has been characterized and partially purified. This high mass methyl-accepting protein (HMAP) is concentrated in rat brain cytosol and is not detectable in rat liver, heart, lung, kidney, or skeletal muscle. HMAP is acidic and heterogeneous in size, with an average mass, as judged by size-exclusion high performance liquid chromatography, greater than 700 kDa. After partial purification from cow brain by anion-exchange chromatography, ammonium sulfate fractionation, and gel filtration, HMAP could accept 12.1 nmol of methyl groups per mg of protein, suggesting that it contains a level of isoaspartate at least 50 times greater than that of the average protein in brain cytosol. Partially purified HMAP is degraded by trypsin, verifying that it is composed, at least in part, of protein. Additional studies on this unusual macromolecule may shed important new light on mechanisms of isoaspartate formation in cells and the molecular pathology of brain aging.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Ghandour, B.-F. Lin, S.-W. Choi, J. B Mason, and J. Selhub Folate Status and Age Affect the Accumulation of L-Isoaspartyl Residues in Rat Liver Proteins J. Nutr., June 1, 2002; 132(6): 1357 - 1360. [Abstract] [Full Text] [PDF]

				J. ORPISZEWSKI, N. SCHORMANN, B. KLUVE-BECKERMAN, J. J. LIEPNIEKS, and M. D. BENSON Protein aging hypothesis of Alzheimer disease FASEB J, June 1, 2000; 14(9): 1255 - 1263. [Abstract] [Full Text]

				C. L. David, J. Keener, and D. W. Aswad Isoaspartate in Ribosomal Protein S11 of Escherichia coli J. Bacteriol., May 1, 1999; 181(9): 2872 - 2877. [Abstract] [Full Text]

				C. L. David, J. Orpiszewski, X.-C. Zhu, K. J. Reissner, and D. W. Aswad Isoaspartate in Chrondroitin Sulfate Proteoglycans of Mammalian Brain J. Biol. Chem., November 27, 1998; 273(48): 32063 - 32070. [Abstract] [Full Text] [PDF]